Authors:
TOMASSETTI A
BOTTERO F
MAZZI M
MIOTTI S
COLNAGHI MI
CANEVARI S
Citation: A. Tomassetti et al., MOLECULAR REQUIREMENTS FOR ATTACHMENT OF THE GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR TO THE HUMAN ALPHA FOLATE RECEPTOR, Journal of cellular biochemistry, 72(1), 1999, pp. 111-118
Authors:
DOSIO F
ARPICCO S
ADOBATI E
CANEVARI S
BRUSA P
DESANTIS R
PARENTE D
PIGNANELLI P
NEGRI DRM
COLNAGHI MI
CATTEL L
Citation: F. Dosio et al., ROLE OF CROSS-LINKING AGENTS IN DETERMINING THE BIOCHEMICAL AND PHARMACOKINETIC PROPERTIES OF MGR6-CLAVIN IMMUNOTOXINS, Bioconjugate chemistry, 9(3), 1998, pp. 372-381
Authors:
FIGINI M
OBICI L
MEZZANZANICA D
GRIFFITHS A
COLNAGHI MI
WINTER G
CANEVARI S
Citation: M. Figini et al., PANNING PHAGE ANTIBODY LIBRARIES ON CELLS - ISOLATION OF HUMAN FAB FRAGMENTS AGAINST OVARIAN-CARCINOMA USING GUIDED SELECTION, Cancer research, 58(5), 1998, pp. 991-996
Authors:
DOLO V
GINESTRA A
CASSARA D
VIOLINI S
LUCANIA G
TORRISI MR
NAGASE H
CANEVARI S
PAVAN A
VITTORELLI ML
Citation: V. Dolo et al., SELECTIVE LOCALIZATION OF MATRIX METALLOPROTEINASE-9, BETA(1) INTEGRINS, AND HUMAN LYMPHOCYTE ANTIGEN CLASS-I MOLECULES ON MEMBRANE-VESICLES SHED BY 8701-BC BREAST-CARCINOMA CELLS, Cancer research, 58(19), 1998, pp. 4468-4474
Authors:
MELANI C
FIGINI M
NICOSIA D
LUISON E
RAMAKRISHNA V
CASORATI G
PARMIANI G
ESHHAR Z
CANEVARI S
COLOMBO MP
Citation: C. Melani et al., TARGETING OF INTERLEUKIN-2 TO HUMAN OVARIAN-CARCINOMA BY FUSION WITH A SINGLE-CHAIN FV OF ANTIFOLATE RECEPTOR ANTIBODY, Cancer research, 58(18), 1998, pp. 4146-4154
Authors:
SFORZINI S
DETOTERO D
GAGGERO A
IPPOLITI R
GLENNIE MJ
CANEVARI S
STEIN H
FERRINI S
Citation: S. Sforzini et al., TARGETING OF SAPORIN TO HODGKINS LYMPHOMA-CELLS BY ANTI-CD30 AND ANTI-CD25 BISPECIFIC ANTIBODIES, British Journal of Haematology, 102(4), 1998, pp. 1061-1068
Authors:
CHINOL M
CASALINI P
MAGGIOLO M
CANEVARI S
OMODEO ES
CALICETI P
VERONESE FM
CREMONESI M
CHIOLERIO F
NARDONE E
SICCARDI AG
PAGANELLI G
Citation: M. Chinol et al., BIOCHEMICAL MODIFICATIONS OF AVIDIN IMPROVE PHARMACOKINETICS AND BIODISTRIBUTION, AND REDUCE IMMUNOGENICITY, British Journal of Cancer, 78(2), 1998, pp. 189-197
Authors:
DOLO V
GINESTRA A
VIOLINI S
MIOTTI S
FESTUCCIA C
MICELI D
MIGLIAVACCA M
RINAUDO C
ROMANO FM
BRISDELLI F
CANEVARI S
PAVAN A
VITTORELLI ML
Citation: V. Dolo et al., ULTRASTRUCTURAL AND PHENOTYPIC CHARACTERIZATION OF CABA-I, A NEW HUMAN OVARIAN-CANCER CELL-LINE, Oncology research, 9(3), 1997, pp. 129-138
Authors:
TOMASSETTI A
MANGIAROTTI F
MAZZI M
COLNAGHI MI
MIOTTI S
NACHMANOFF K
CANEVARI S
ELWOOD PC
Citation: A. Tomassetti et al., TRANSCRIPTIONAL REGULATION OF THE HUMAN ALPHA-FOLATE RECEPTOR - FUNCTIONAL-ANALYSIS OF THE P1 AND P4 PROMOTERS IN OVARIAN-CARCINOMA CELL-LINES, The FASEB journal, 11(9), 1997, pp. 456-456
Authors:
MELANI C
FIGINI M
NICOSIA D
TOMASSETTI A
CASORATI G
PARMIANI G
CANEVARI S
COLOMBO MP
Citation: C. Melani et al., INTERLEUKIN-2 MOV19 SCFV ANTIBODY FUSION PROTEIN FOR SPECIFIC, ANTIGEN-MEDIATED TUMOR TARGETING/, The FASEB journal, 11(9), 1997, pp. 1738-1738
Authors:
MIOTTI S
BAGNOLI M
OTTONE F
TOMASSETTI A
COLNAGHI MI
CANEVARI S
Citation: S. Miotti et al., SIMULTANEOUS ACTIVITY OF 2 DIFFERENT MECHANISMS OF FOLATE TRANSPORT IN OVARIAN-CARCINOMA CELL-LINES, Journal of cellular biochemistry, 65(4), 1997, pp. 479-491
Authors:
CANEVARI S
MEZZANZANICA D
MAZZONI A
NEGRI DRM
FIGINI M
RAMAKRISHNA V
BOLIS G
COLNAGHI MI
Citation: S. Canevari et al., APPROACHES TO IMPLEMENT BISPECIFIC ANTIBODY TREATMENT OF OVARIAN-CARCINOMA, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 187-189
Authors:
JACOBS N
MAZZONI A
MEZZANZANICA D
NEGRI DRM
VALOTA O
COLNAGHI MI
MOUTSCHEN MP
BONIVER J
CANEVARI S
Citation: N. Jacobs et al., EFFICIENCY OF T-CELL TRIGGERING BY ANTI-CD3 MONOCLONAL-ANTIBODIES (MAB) WITH POTENTIAL USEFULNESS IN BISPECIFIC MAB GENERATION, Cancer immunology and immunotherapy, 44(5), 1997, pp. 257-264
Authors:
BOTTI C
NEGRI DRM
SEREGNI E
RAMAKRISHNA V
ARIENTI F
MAFFIOLI L
LOMBARDO C
BOGNI A
PASCALI C
CRIPPA F
MASSARON S
REMONTI F
NERINIMOLTENI S
CANEVARI S
BOMBARDIERI E
Citation: C. Botti et al., COMPARISON OF 3 DIFFERENT METHODS FOR RADIOLABELING HUMAN ACTIVATED T-LYMPHOCYTES, European journal of nuclear medicine, 24(5), 1997, pp. 497-504
Authors:
CASALINI P
LUISON E
MENARD S
COLNAGHI MI
PAGANELLI G
CANEVARI S
Citation: P. Casalini et al., TUMOR PRETARGETING - ROLE OF AVIDIN STREPTAVIDIN ON MONOCLONAL-ANTIBODY INTERNALIZATION/, The Journal of nuclear medicine, 38(9), 1997, pp. 1378-1381
Authors:
CHINOL M
MAGGIOLO M
OMODEO ES
CANEVARI S
CASALINI P
PAGANELLI G
Citation: M. Chinol et al., PHARMACOKINETICS AND BIODISTRIBUTION OF CHEMICALLY-MODIFIED AVIDINS, The Journal of nuclear medicine, 38(5), 1997, pp. 765-765
Authors:
RAMAKRISHNA V
NEGRI DRM
BRUSIC V
FONTANELLI R
CANEVARI S
BOLIS G
CASTELLI C
PARMIANI G
Citation: V. Ramakrishna et al., GENERATION AND PHENOTYPIC CHARACTERIZATION OF NEW HUMAN OVARIAN-CANCER CELL-LINES WITH THE IDENTIFICATION OF ANTIGENS POTENTIALLY RECOGNIZABLE BY HLA-RESTRICTED CYTOTOXIC T-CELLS, International journal of cancer, 73(1), 1997, pp. 143-150
Authors:
MIOTTI S
BAGNOLI M
TOMASSETTI A
COLNAGHI MI
CANEVARI S
Citation: S. Miotti et al., FOLATE RECEPTOR IN DETERGENT-RESISTANT COMPLEXES FROM THE OVARIAN-CARCINOMA CELL-LINE IGROVI IS ASSOCIATED TO P53-50 LYN IN THE ABSENCE OF CAVEOLIN, Molecular biology of the cell, 7, 1996, pp. 1590-1590
Authors:
TOSI E
VALOTA O
CANEVARI S
ADOBATI E
CASALINI P
PEREZ P
COLNAGHI MI
Citation: E. Tosi et al., ANTIIDIOTYPIC RESPONSE TO ANTIGROWTH FACTOR-RECEPTOR MONOCLONAL-ANTIBODIES, European journal of cancer, 32A(3), 1996, pp. 498-505
Citation: S. Canevari et al., 1975-1995 REVISED ANTICANCER SEROLOGICAL RESPONSE - BIOLOGICAL SIGNIFICANCE AND CLINICAL IMPLICATIONS, Annals of oncology, 7(3), 1996, pp. 227-232
Authors:
PARENTE D
RAUCCI G
CELANO B
PACILLI A
ZANONI L
CANEVARI S
ADOBATI E
COLNAGHI ML
DOSIO F
ARPICCO S
CATTEL L
MELE A
DESANTIS R
Citation: D. Parente et al., CLAVIN A TYPE-1 RIBOSOME-INACTIVATING PROTEIN FROM ASPERGILLUS-CLAVATUS IFO-8605 - CDNA ISOLATION, HETEROLOGOUS EXPRESSION, BIOCHEMICAL ANDBIOLOGICAL CHARACTERIZATION OF THE RECOMBINANT PROTEIN, European journal of biochemistry, 239(2), 1996, pp. 272-280
Authors:
MAZZONI A
MEZZANZANICA D
JUNG GR
WOLF H
COLNAGHI MI
CANEVARI S
Citation: A. Mazzoni et al., CD3-CD28 COSTIMULATION AS A MEANS TO AVOIDING T-CELL PREACTIVATION INBISPECIFIC MONOCLONAL ANTIBODY-BASED TREATMENT OF OVARIAN-CARCINOMA, Cancer research, 56(23), 1996, pp. 5443-5449